Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results entities : Johnson & johnson save search
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Johnson & Johnson Reports Q1 2024 Results
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
results
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
TRIB | $1.81 -3.72% -3.87% 5.7K
|
Health Technology
|
| O: -0.99%
H: 2.0%
C: 2.0%
biotech business year financial results
Titan Medical Reports Fiscal Year 2023 Results
Published: 2024-03-29 (Crawled : 22:00) - globenewswire.com
TMDI | $0.14 -26.32% -35.52% 0
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
year medical results
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
business year financial results
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
OABI | $4.67 1.74% 1.71% 930K
|
|
| O: -0.76%
H: 4.02%
C: 3.63%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
business year financial results
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
ACIU | $2.375 -0.21% -0.21% 320K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -11.67%
year update financial results
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 1.08%
H: 3.77%
C: 1.97%
biotech year results
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
MRSN | $3.255 -2.55% -2.61% 2.4M
|
Health Technology
|
| O: -5.39%
H: 24.13%
C: 20.05%
business year update therapeutics financial results
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: 0.3%
H: 1.25%
C: -0.1%
year update financial results
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.2%
H: 2.52%
C: 1.3%
year financial results
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
LIVN | $52.31 -0.85% -0.86% 430K
|
Health Technology
|
| O: 5.51%
H: 4.14%
C: 2.38%
results
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
MURA | $3.55 -0.56% -0.56% 240K
|
|
| O: 2.78%
H: 8.11%
C: 3.53%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 2.72%
H: 13.77%
C: 13.25%
year financial results
Royalty Pharma Reports Q4 and Full Year 2023 Results
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.26%
H: 3.99%
C: 1.21%
pharma year royalty results
Kenvue Reports Full Year and Fourth Quarter 2023 Results
Published: 2024-02-08 (Crawled : 12:30) - biospace.com/
KVUE 4 | $19.58 0.72% 9.5M
|
n/a
|
| O: -3.27%
H: 0.98%
C: -2.62%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
year results
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Published: 2024-02-07 (Crawled : 22:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: -0.04%
H: 4.09%
C: 2.8%
jnj-2113 psoriasis positive results study
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.27%
H: 20.82%
C: 11.51%
year pharmaceuticals financial results
J&J Touts Positive Phase III Results for Antibody in Autoimmune Disorders
Published: 2024-02-06 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
antibody positive disorders results
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Published: 2024-01-30 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.49%
H: 0.14%
C: -0.94%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.07%
H: 0.44%
C: -1.08%
pharma year royalty financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.